HIV-1 envelope glycoprotein (Env), a gp120–gp41 trimer, undergoes coordinated conformational changes that drive membrane fusion and allow immune evasion by transiently concealing ...
Switching to integrase strand transfer inhibitors (INSTI) from protease inhibitors is associated with new diabetes risk in people with HIV.
Switching to INSTI-based ART from protease inhibitors is associated with an increased risk for incident diabetes in treatment-experienced adults.
For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...
A cornerstone of the effort to combat the nation's HIV epidemic is beginning to show fiscal cracks. The Ryan White HIV/AIDS Program has helped more than a quarter million Americans living with HIV to ...
More than 20 states are actively reducing or considering cutting back on their funding of programs helping people access HIV medications, as federal funding fails to keep up with the costs, according ...
More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...
Though Gilead Sciences made waves last June with a landmark FDA approval for its twice-yearly HIV preventive Yeztugo (lenacapavir), the first-in-class drug had previously been used as a long-acting ...
The US government paused all foreign assistance in January 2025. This abrupt decision affected the delivery of life-saving HIV medicines and the provision of HIV prevention services to millions of ...
I’ve spent much of my career caring for people in places most Americans never see. I’ve worked in refugee camps, on the streets of large cities, in rural communities cut off from care, in clinics ...
Add Yahoo as a preferred source to see more of our stories on Google. Carole Treston had been a nurse early in her career when she and her mother traveled to Washington, D.C., and saw the AIDS ...